-
-
-
-
-
-
-
Biogen (BIIB) Could Become a Strategic Asset - Jefferies
-
-
-
-
-
-
-
Biogen (BIIB) Expert Call Highlights Difficulties with Aduhelm Launch, Numbers Need to Come Down - Jefferies
-
-
-
-
-
-
-
Biogen (BIIB) Physician Survey Indicates Upside to Street Estimates - Jefferies
-
-
-
-
-
-
-
Biogen (BIIB) Falls After Cautious Comments During Jefferies Call - Bloomberg
-
-
-
-
-
-
-
Biogen (BIIB) PT Raised to $310 at Jefferies
-
-
-
-
-
-
-
Jefferies Assumes Biogen (BIIB) at Hold
-
-
-
-
-
-
-
Notable Analyst Rating Changes 9/6: (EQIX) (FNSR) (HP) Upgraded; (BIIB) (CACC) (CSTM) Downgraded
-
56,419 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All